DeepMind's AlphaGenome 2 Reads DNA One Cell Type at a Time
Google DeepMind announced AlphaGenome 2 on Wednesday, November 11, a next-generation DNA sequence model that predicts how genetic variants affect individual human cell types and cell states, rather than averaging their effects across whole tissues. The model is available now for non-commercial research through the AlphaGenome API, with commercial research access offered in private preview.